Disclosure Of Entity's Operating Segments [Text Block]

Cinclus Pharma Holding AB - Filing #5879291

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Disclosure of entity's operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Profit (loss) before tax	167 281 SEK	—	—	—	—	—	—	—	214 613 SEK	—	—	—
Profit (loss)	168 031 SEK	– SEK	—	– SEK	– SEK	168 031 SEK	– SEK	– SEK	215 118 SEK	—	215 118 SEK	– SEK
Assets	—	—	601 013 SEK	—	—	—	—	—	—	94 413 SEK	—	—
Liabilities	—	—	45 683 SEK	—	—	—	—	—	—	171 213 SEK	—	—
Cash flows from (used in) operating activities	178 367 SEK	—	—	—	—	—	—	—	209 186 SEK	—	—	—
Cash flows from (used in) financing activities	655 200 SEK	—	—	—	—	—	—	—	122 892 SEK	—	—	—